NANCY WILDING: Open Payments
NPI 1851620504 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 17 payments from 11 companies in 2025. Trend: 2023 $37 · 2024 $690 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $160 |
| ABBVIE INC. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $122 |
| ABIOMED | 1 | $94 |
| Novo Nordisk Inc | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Exeltis, USA Inc. | 1 | $31 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $20 |
Products named: Kerendia, MAVYRET, VOQUEZNA, SHINGRIX, VERQUVO, Ozempic, TWIRLA, NEXLETOL.
Industry payments across KY — which companies pay providers there.
